Corcept Therapeutics, Inc. (CORT)
72.77
+1.14
(+1.59%)
USD |
NASDAQ |
Nov 06, 16:00
72.76
-0.01
(-0.01%)
After-Hours: 20:00
Corcept Therapeutics Free Cash Flow : 194.62M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | 194.62M |
| June 30, 2026 | 106.92M |
| March 31, 2026 | 119.79M |
| December 31, 2025 | 141.43M |
| September 30, 2025 | 162.21M |
| June 30, 2025 | 179.92M |
| March 31, 2025 | 176.80M |
| December 31, 2024 | 195.90M |
| September 30, 2024 | 142.60M |
| June 30, 2024 | 123.28M |
| March 31, 2024 | 124.70M |
| December 31, 2023 | 126.90M |
| September 30, 2023 | 154.37M |
| June 30, 2023 | 134.80M |
| March 31, 2023 | 110.63M |
| December 31, 2022 | 119.91M |
| September 30, 2022 | 135.92M |
| June 30, 2022 | 151.16M |
| March 31, 2022 | 177.36M |
| December 31, 2021 | 167.42M |
| September 30, 2021 | 152.70M |
| June 30, 2021 | 133.88M |
| March 31, 2021 | 142.80M |
| December 31, 2020 | 150.73M |
| September 30, 2020 | 164.41M |
| Date | Value |
|---|---|
| June 30, 2020 | 172.83M |
| March 31, 2020 | 144.83M |
| December 31, 2019 | 135.03M |
| September 30, 2019 | 108.12M |
| June 30, 2019 | 114.44M |
| March 31, 2019 | 104.44M |
| December 31, 2018 | 115.37M |
| September 30, 2018 | 118.82M |
| June 30, 2018 | 85.20M |
| March 31, 2018 | 85.42M |
| December 31, 2017 | 60.52M |
| September 30, 2017 | 40.16M |
| June 30, 2017 | 38.16M |
| March 31, 2017 | 24.37M |
| December 31, 2016 | 18.20M |
| September 30, 2016 | 17.88M |
| June 30, 2016 | 9.921M |
| March 31, 2016 | 8.199M |
| December 31, 2015 | 3.113M |
| September 30, 2015 | -2.47M |
| June 30, 2015 | -9.298M |
| March 31, 2015 | -18.19M |
| December 31, 2014 | -27.55M |
| September 30, 2014 | -33.85M |
| June 30, 2014 | -36.58M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 11.79B |
| Phibro Animal Health Corp. | 9.866M |
| Illumina, Inc. | 637.00M |
| Eli Lilly & Co. | 11.69B |
| Merck & Co., Inc. | 14.75B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 142.89M |
| Cash from Investing (Quarterly) | -131.99M |
| Cash from Financing (Quarterly) | -23.88M |
| Free Cash Flow Per Share (Quarterly) | 1.154 |
| Free Cash Flow to Equity (Quarterly) | 142.61M |
| Free Cash Flow to Firm (Quarterly) | 142.18M |
| Free Cash Flow Yield | 2.30% |